Allergan (AGN) Tops Q1 EPS by 39c, Offers FY & Q2 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500 set for muted open after big bank earnings, chip slide weighs
- Oil eases as traders monitor Russian diesel deal, Saudi attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Tweet
Share
E-mail
Get Alerts AGN Hot Sheet
Join SI Premium – FREE
Allergan (NYSE: AGN) reported Q1 EPS of $3.74, $0.39 better than the analyst estimate of $3.35. Revenue for the quarter came in at $3.67 billion versus the consensus estimate of $3.59 billion.
GUIDANCE:
Allergan sees 2018 EPS of $15.65-$16.25, versus the consensus of $15.65. Allergan sees 2018 revenue of $15.15-15.35 billion, versus the consensus of $15.22 billion.
Allergan sees Q2 2018 EPS of $4.00-$4.20, versus the consensus of $3.94. Allergan sees Q2 2018 revenue of $3.85-4 billion, versus the consensus of $3.84 billion.
For earnings history and earnings-related data on Allergan (AGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Upgrades Telefonica S.A. (VIV) to Neutral
- Citi lifts Galaxy and Gemini, downgrades Securitize as crypto fundamentals improve
- UnitedHealth Group (UNH) Tops Q3 EPS by 57c, Beats on Revenue; Offers FY EPS Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
